Skip to content

Insider · CIK 0001320932

H Erin Xie

other

Files at BME (BlackRock Health Sciences Trust), BMEZ (BlackRock Health Sciences Term Trust). First filing -, latest -.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jan 31, 2025BMEZ
BlackRock Health Sciences Term Trust
MOption exercise
Common Stock
+14,883--14,883Feb 4, 2025
Jan 31, 2025BME
BlackRock Health Sciences Trust
MOption exercise
Common Stock
+13,471--13,471Feb 4, 2025
Jan 31, 2025BMEZ
BlackRock Health Sciences Term Trust
DDisposition to issuer
Common Stock
-14,883$16.49$245k0Feb 4, 2025
Jan 31, 2025BME
BlackRock Health Sciences Trust
DDisposition to issuer
Common Stock
-13,471$40.92$551k0Feb 4, 2025
Jan 31, 2025BMEZ
BlackRock Health Sciences Term Trust
AGrant or award
Phantom Sharesderivative
+23,650$16.49$390k23,650Feb 4, 2025
Jan 31, 2025BME
BlackRock Health Sciences Trust
AGrant or award
Phantom Sharesderivative
+9,530$40.92$390k9,530Feb 4, 2025
Jan 31, 2025BMEZ
BlackRock Health Sciences Term Trust
MOption exercise
Phantom Sharesderivative
-7,836--15,671Feb 4, 2025
Jan 31, 2025BME
BlackRock Health Sciences Trust
MOption exercise
Phantom Sharesderivative
-2,774--5,547Feb 4, 2025
Jan 31, 2025BMEZ
BlackRock Health Sciences Term Trust
MOption exercise
Phantom Sharesderivative
-7,047--7,047Feb 4, 2025
Jan 31, 2025BME
BlackRock Health Sciences Trust
MOption exercise
Phantom Sharesderivative
-4,588--4,588Feb 4, 2025
Jan 31, 2025BME
BlackRock Health Sciences Trust
MOption exercise
Phantom Sharesderivative
-6,110--0Feb 4, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

H Erin Xie: insider trades and track record | InsiderTell